Clinical trial
Prospective Evaluation of COVID-19 Vaccine Induced Immunity
NCT04713163 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of COVID-19 Vaccine Induced Immunity
- Lead sponsor
- University of Manitoba
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2021
- Completion date
- December 31, 2021
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
covid19